|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 170 for Tnfrsf11a

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.041s

Categories

Category: Publication
Type Details Score
Publication
First Author: Alonso N
Year: 2021
Journal: J Bone Miner Res
Title: Insertion Mutation in Tnfrsf11a Causes a Paget's Disease-Like Phenotype in Heterozygous Mice and Osteopetrosis in Homozygous Mice.
Volume: 36
Issue: 7
Pages: 1376-1386
Publication
First Author: Rios D
Year: 2016
Journal: Mucosal Immunol
Title: Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria.
Volume: 9
Issue: 4
Pages: 907-16
Publication
First Author: Luo J
Year: 2016
Journal: Nat Med
Title: LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
Volume: 22
Issue: 5
Pages: 539-46
Publication
First Author: Donaldson DS
Year: 2020
Journal: iScience
Title: Microbial Stimulation Reverses the Age-Related Decline in M Cells in Aged Mice.
Volume: 23
Issue: 6
Pages: 101147
Publication  
First Author: Chen X
Year: 2018
Journal: Bone Res
Title: RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation.
Volume: 6
Pages: 34
Publication
First Author: Yoldi G
Year: 2016
Journal: Cancer Res
Title: RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.
Volume: 76
Issue: 19
Pages: 5857-5869
Publication
First Author: Li J
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.
Volume: 97
Issue: 4
Pages: 1566-71
Publication
First Author: Kostenuik PJ
Year: 2009
Journal: J Bone Miner Res
Title: Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.
Volume: 24
Issue: 2
Pages: 182-95
Publication
First Author: Dougall WC
Year: 1999
Journal: Genes Dev
Title: RANK is essential for osteoclast and lymph node development.
Volume: 13
Issue: 18
Pages: 2412-24
Publication
First Author: Iwamoto T
Year: 2001
Journal: J Biol Chem
Title: Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-kappa B ligand.
Volume: 276
Issue: 49
Pages: 46031-8
Publication
First Author: Xu D
Year: 2006
Journal: J Biol Chem
Title: A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage.
Volume: 281
Issue: 8
Pages: 4678-90
Publication
First Author: Gonzalez-Suarez E
Year: 2007
Journal: Mol Cell Biol
Title: RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.
Volume: 27
Issue: 4
Pages: 1442-54
Publication
First Author: Poblenz AT
Year: 2007
Journal: Biochem Biophys Res Commun
Title: Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides.
Volume: 359
Issue: 3
Pages: 510-5
Publication
First Author: Kim H
Year: 2009
Journal: J Clin Invest
Title: Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.
Volume: 119
Issue: 4
Pages: 813-25
Publication
First Author: Taguchi Y
Year: 2009
Journal: Genes Cells
Title: A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals.
Volume: 14
Issue: 11
Pages: 1331-45
Publication
First Author: Pellegrini P
Year: 2013
Journal: Stem Cells
Title: Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
Volume: 31
Issue: 9
Pages: 1954-65
Publication
First Author: Li Y
Year: 2019
Journal: J Bone Miner Res
Title: Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis.
Volume: 34
Issue: 10
Pages: 1938-1951
Publication
First Author: Paolino M
Year: 2021
Journal: Nature
Title: RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy.
Volume: 589
Issue: 7842
Pages: 442-447
Publication
First Author: Kim N
Year: 2002
Journal: J Exp Med
Title: A novel member of the leukocyte receptor complex regulates osteoclast differentiation.
Volume: 195
Issue: 2
Pages: 201-9
Publication
First Author: Perlot T
Year: 2012
Journal: J Immunol
Title: Development and function of murine B cells lacking RANK.
Volume: 188
Issue: 3
Pages: 1201-5
Publication
First Author: Chen L
Year: 2008
Journal: Eur J Immunol
Title: IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells.
Volume: 38
Issue: 10
Pages: 2845-54
Publication
First Author: Anderson DM
Year: 1997
Journal: Nature
Title: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Volume: 390
Issue: 6656
Pages: 175-9
Publication
First Author: Ta HM
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.
Volume: 107
Issue: 47
Pages: 20281-6
Publication    
First Author: Su W
Year: 2022
Journal: Elife
Title: Senescent preosteoclast secretome promotes metabolic syndrome associated osteoarthritis through cyclooxygenase 2.
Volume: 11
Publication
First Author: Takemura K
Year: 2010
Journal: Biochem Biophys Res Commun
Title: Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-kappaB (RANK).
Volume: 391
Issue: 4
Pages: 1675-80
Publication
First Author: Kiechl S
Year: 2013
Journal: Nat Med
Title: Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.
Volume: 19
Issue: 3
Pages: 358-63
Publication
First Author: Szwarc MM
Year: 2015
Journal: PLoS One
Title: Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.
Volume: 10
Issue: 6
Pages: e0128467
Publication
First Author: Kapur RP
Year: 2004
Journal: J Bone Miner Res
Title: Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
Volume: 19
Issue: 10
Pages: 1689-97
Publication
First Author: Yu TY
Year: 2015
Journal: PLoS One
Title: Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.
Volume: 10
Issue: 1
Pages: e0117112
Publication
First Author: Fata JE
Year: 2000
Journal: Cell
Title: The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.
Volume: 103
Issue: 1
Pages: 41-50
Publication
First Author: Knoop KA
Year: 2009
Journal: J Immunol
Title: RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium.
Volume: 183
Issue: 9
Pages: 5738-47
Publication  
First Author: Lee NJ
Year: 2018
Journal: Neuropeptides
Title: Central RANK signalling in NPY neurons alters bone mass in male mice.
Volume: 68
Pages: 75-83
Publication
First Author: Rao M
Year: 2015
Journal: Exp Hematol
Title: Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice.
Volume: 43
Issue: 2
Pages: 110-4.e1-2
Publication
First Author: Beristain AG
Year: 2012
Journal: J Cell Sci
Title: Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells.
Volume: 125
Issue: Pt 4
Pages: 943-55
Publication
First Author: Dufresne SS
Year: 2016
Journal: Am J Physiol Cell Physiol
Title: Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles.
Volume: 310
Issue: 8
Pages: C663-72
Publication
First Author: Kwon OH
Year: 2005
Journal: Biochem Biophys Res Commun
Title: The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Volume: 335
Issue: 2
Pages: 437-46
Publication
First Author: Pierroz DD
Year: 2010
Journal: J Biol Chem
Title: Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
Volume: 285
Issue: 36
Pages: 28164-73
Publication
First Author: Kanazawa K
Year: 2005
Journal: J Bone Miner Res
Title: Self-assembled RANK induces osteoclastogenesis ligand-independently.
Volume: 20
Issue: 11
Pages: 2053-60
Publication
First Author: Totsuka T
Year: 2009
Journal: J Immunol
Title: RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Volume: 182
Issue: 10
Pages: 6079-87
Publication
First Author: Hakozaki A
Year: 2010
Journal: J Immunol
Title: Receptor activator of NF-kappaB (RANK) ligand induces ectodomain shedding of RANK in murine RAW264.7 macrophages.
Volume: 184
Issue: 5
Pages: 2442-8
Publication
First Author: Tan W
Year: 2011
Journal: Nature
Title: Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.
Volume: 470
Issue: 7335
Pages: 548-53
Publication
First Author: Duheron V
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.
Volume: 108
Issue: 13
Pages: 5342-7
Publication
First Author: Hess E
Year: 2012
Journal: J Immunol
Title: RANKL induces organized lymph node growth by stromal cell proliferation.
Volume: 188
Issue: 3
Pages: 1245-54
Publication
First Author: Gutierrez H
Year: 2013
Journal: Open Biol
Title: Regulation of neurite growth by tumour necrosis superfamily member RANKL.
Volume: 3
Issue: 1
Pages: 120150
Publication
First Author: Nelson CA
Year: 2012
Journal: Structure
Title: RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.
Volume: 20
Issue: 11
Pages: 1971-82
Publication
First Author: Zhao B
Year: 2012
Journal: J Exp Med
Title: TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Volume: 209
Issue: 2
Pages: 319-34
Publication
First Author: Joshi PA
Year: 2015
Journal: Stem Cell Reports
Title: RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1.
Volume: 5
Issue: 1
Pages: 31-44
Publication
First Author: Arai A
Year: 2019
Journal: J Bone Miner Res
Title: Beclin1 Modulates Bone Homeostasis by Regulating Osteoclast and Chondrocyte Differentiation.
Volume: 34
Issue: 9
Pages: 1753-1766
Publication
First Author: Greenblatt MB
Year: 2015
Journal: J Exp Med
Title: CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.
Volume: 212
Issue: 8
Pages: 1283-301
Publication
First Author: Bando JK
Year: 2018
Journal: Immunity
Title: The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.
Volume: 48
Issue: 6
Pages: 1208-1219.e4
Publication
First Author: Arai A
Year: 2012
Journal: J Cell Sci
Title: Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
Volume: 125
Issue: Pt 12
Pages: 2910-7
Publication
First Author: Rao S
Year: 2017
Journal: Genes Dev
Title: RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.
Volume: 31
Issue: 20
Pages: 2099-2112
Publication
First Author: Wood MB
Year: 2016
Journal: Am J Physiol Cell Physiol
Title: TNF-α augments RANKL-dependent intestinal M cell differentiation in enteroid cultures.
Volume: 311
Issue: 3
Pages: C498-507
Publication
First Author: Hsu YH
Year: 2011
Journal: J Exp Med
Title: Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss.
Volume: 208
Issue: 9
Pages: 1849-61
Publication
First Author: Rossi SW
Year: 2007
Journal: J Exp Med
Title: RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla.
Volume: 204
Issue: 6
Pages: 1267-72
Publication
First Author: Powell JJ
Year: 2015
Journal: Nat Nanotechnol
Title: An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells.
Volume: 10
Issue: 4
Pages: 361-9
Publication
First Author: Habbeddine M
Year: 2017
Journal: Cell Rep
Title: Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone.
Volume: 21
Issue: 9
Pages: 2515-2527
Publication
First Author: Donaldson DS
Year: 2016
Journal: PLoS Pathog
Title: Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease Susceptibility.
Volume: 12
Issue: 12
Pages: e1006075
Publication
First Author: Schramek D
Year: 2010
Journal: Nature
Title: Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.
Volume: 468
Issue: 7320
Pages: 98-102
Publication
First Author: Klauzinska M
Year: 2015
Journal: Am J Pathol
Title: Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
Volume: 185
Issue: 11
Pages: 2907-22
Publication
First Author: Loyher PL
Year: 2018
Journal: J Exp Med
Title: Macrophages of distinct origins contribute to tumor development in the lung.
Volume: 215
Issue: 10
Pages: 2536-2553
Publication
First Author: Lee YM
Year: 2010
Journal: Int Immunol
Title: IL-1 plays an important role in the bone metabolism under physiological conditions.
Volume: 22
Issue: 10
Pages: 805-16
Publication
First Author: Guerrini MM
Year: 2015
Journal: Immunity
Title: Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Volume: 43
Issue: 6
Pages: 1174-85
Publication
First Author: Shimamura M
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
Volume: 111
Issue: 22
Pages: 8191-6
Publication
First Author: Matsuo FS
Year: 2020
Journal: Am J Physiol Endocrinol Metab
Title: RANKL induces beige adipocyte differentiation in preadipocytes.
Volume: 318
Issue: 6
Pages: E866-E877
Publication
First Author: Desanti GE
Year: 2012
Journal: J Immunol
Title: Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla.
Volume: 189
Issue: 12
Pages: 5519-26
Publication
First Author: Serrano EM
Year: 2009
Journal: Biochem Biophys Res Commun
Title: Regulation of vacuolar H(+)-ATPase in microglia by RANKL.
Volume: 389
Issue: 1
Pages: 193-7
Publication
First Author: Ohazama A
Year: 2004
Journal: J Dent Res
Title: Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis.
Volume: 83
Issue: 3
Pages: 241-4
Publication
First Author: Khapli SM
Year: 2010
Journal: Biochem Biophys Res Commun
Title: Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis.
Volume: 399
Issue: 4
Pages: 688-93
Publication
First Author: Zhao Y
Year: 2013
Journal: FEBS Lett
Title: Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANK.
Volume: 587
Issue: 18
Pages: 2958-64
Publication  
First Author: Aoyama E
Year: 2015
Journal: Bone
Title: CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG.
Volume: 73
Pages: 242-8
Publication  
First Author: Macari S
Year: 2018
Journal: Bone
Title: Lactation induces increases in the RANK/RANKL/OPG system in maxillary bone.
Volume: 110
Pages: 160-169
Publication
First Author: Weinberger T
Year: 2020
Journal: Nat Commun
Title: Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation.
Volume: 11
Issue: 1
Pages: 4549
Publication
First Author: Maeda K
Year: 2012
Journal: Nat Med
Title: Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Volume: 18
Issue: 3
Pages: 405-12
Publication
First Author: Jacome-Galarza CE
Year: 2019
Journal: Nature
Title: Developmental origin, functional maintenance and genetic rescue of osteoclasts.
Volume: 568
Issue: 7753
Pages: 541-545
Publication
First Author: Leung R
Year: 2011
Journal: Blood
Title: Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis.
Volume: 117
Issue: 6
Pages: 2044-53
Publication
First Author: Gómez-Aleza C
Year: 2020
Journal: Nat Commun
Title: Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.
Volume: 11
Issue: 1
Pages: 6335
Publication
First Author: Bosch-Marcé M
Year: 2011
Journal: Hum Mol Genet
Title: Increased IGF-1 in muscle modulates the phenotype of severe SMA mice.
Volume: 20
Issue: 9
Pages: 1844-53
Publication
First Author: Jiang D
Year: 2022
Journal: Immunity
Title: Neuronal signal-regulatory protein alpha drives microglial phagocytosis by limiting microglial interaction with CD47 in the retina.
Volume: 55
Issue: 12
Pages: 2318-2335.e7
Publication  
First Author: Camara A
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: CD169+ macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling.
Volume: 119
Issue: 3
Publication
First Author: Fonseca TL
Year: 2011
Journal: J Bone Miner Res
Title: Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
Volume: 26
Issue: 3
Pages: 591-603
Publication
First Author: Collin-Osdoby P
Year: 2004
Journal: Circ Res
Title: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
Volume: 95
Issue: 11
Pages: 1046-57
Publication
First Author: Kobayashi Y
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.
Volume: 463
Issue: 4
Pages: 1278-83
Publication
First Author: Ju JH
Year: 2008
Journal: J Immunol
Title: IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model.
Volume: 181
Issue: 2
Pages: 1507-18
Publication
First Author: Iqbal J
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.
Volume: 103
Issue: 40
Pages: 14925-30
Publication
First Author: Lee HJ
Year: 2013
Journal: Development
Title: Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.
Volume: 140
Issue: 7
Pages: 1397-401
Publication
First Author: Li P
Year: 2004
Journal: J Bone Miner Res
Title: RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Volume: 19
Issue: 2
Pages: 207-13
Publication
First Author: Jin W
Year: 2008
Journal: J Clin Invest
Title: Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
Volume: 118
Issue: 5
Pages: 1858-66
Publication
First Author: Sigl V
Year: 2016
Journal: Cell Res
Title: RANKL/RANK control Brca1 mutation- .
Volume: 26
Issue: 7
Pages: 761-74
Publication
First Author: Nishikawa K
Year: 2021
Journal: EMBO Rep
Title: Osteoclasts adapt to physioxia perturbation through DNA demethylation.
Volume: 22
Issue: 12
Pages: e53035
Publication
First Author: Liu X
Year: 2013
Journal: J Exp Med
Title: USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.
Volume: 210
Issue: 8
Pages: 1575-90
Publication
First Author: Chen Y
Year: 2015
Journal: Sci Transl Med
Title: RANKL blockade prevents and treats aggressive osteosarcomas.
Volume: 7
Issue: 317
Pages: 317ra197
Publication
First Author: Ortega N
Year: 2010
Journal: Dis Model Mech
Title: Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
Volume: 3
Issue: 3-4
Pages: 224-35
Publication
First Author: Aïoub M
Year: 2007
Journal: Bone
Title: Msx2 -/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis.
Volume: 41
Issue: 5
Pages: 851-9
Publication
First Author: Nitta T
Year: 2020
Journal: Nat Immunol
Title: Fibroblasts as a source of self-antigens for central immune tolerance.
Volume: 21
Issue: 10
Pages: 1172-1180
Publication
First Author: Ohshima D
Year: 2011
Journal: Biochem Biophys Res Commun
Title: RANK signaling induces interferon-stimulated genes in the fetal thymic stroma.
Volume: 408
Issue: 4
Pages: 530-6
Publication
First Author: Yamano T
Year: 2019
Journal: J Exp Med
Title: Aire-expressing ILC3-like cells in the lymph node display potent APC features.
Volume: 216
Issue: 5
Pages: 1027-1037
Publication  
First Author: Ozaki K
Year: 2019
Journal: Sci Signal
Title: The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
Volume: 12
Issue: 589
Publication
First Author: Dejaeger M
Year: 2017
Journal: J Bone Miner Res
Title: Integrin-Linked Kinase Regulates Bone Formation by Controlling Cytoskeletal Organization and Modulating BMP and Wnt Signaling in Osteoprogenitors.
Volume: 32
Issue: 10
Pages: 2087-2102
Publication
First Author: Hirai T
Year: 2015
Journal: Endocrinology
Title: Bone Is a Major Target of PTH/PTHrP Receptor Signaling in Regulation of Fetal Blood Calcium Homeostasis.
Volume: 156
Issue: 8
Pages: 2774-80